Bolt Biotherapeutics Competitors and Similar CompaniesClear all

TC BioPharm's competitors and similar companies include NextCure.

	TC BioPharm TC Biopharm (Holdings) is a clinical-stage cell therapy company developing immunotherapy products.	NextCure NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.
Founding Date	Founding Date 2013	Founding Date 2015
Type	Type Public	Type Public
Tags	Tags Technology biotech clinical research oncology platform therapy	Tags Healthcare Technology biotech drug development oncology pharma platform therapy
Locations	Locations Holytown, GB HQ Leiden, NL Edinburgh, GB London, GB	Locations Beltsville, US HQ
Employees	Employees 41	Employees N/A
Valuation ($)	Valuation ($) 926.7 k	Valuation ($) 39.2 m
Financial
Net income	Net income (£12.2m) (FY, 2024)	Net income ($55.8m) (FY, 2025)
Funding
Total funding raised	Total funding raised $ 33.2m	Total funding raised $ 160m

For sources of this data, please see the company profile

Beltsville, US

NextCure is a biopharmaceutical company focused on discovering and developing next-generation immuno-oncology-based drugs.

Financial